eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2007
vol. 24
 
Share:
Share:
abstract:

The level of bFGF and TGF-beta 1 in alopecia areata patients’ sera and their role in angiogenesis

Grażyna Chodorowska
,
Małgorzata Dąbrowska-Członka
,
Joanna Bartosińska
,
Bartłomiej Wawrzycki
,
Iwona Jazienicka

Post Dermatol Alergol 2007; XXIV, 3: 116–119
Online publish date: 2007/06/22
View full text Get citation
 
Alopecia areata (AA) is regarded as a non-scarring, inflammatory disease of the hair follicle. The pathophysiology of abnormal hair cycle with premature catagen development in this disease remains unknown. Angiogenesis is defined as the growth of new capillaries from pre-existing blood vessels. In the adult skin this process physiologically occurs in the dermis around anagen hair follicles. Furthermore, anagen follicles possess angiogenic properties. The data suggest that inhibiting angiogenesis leads to retardation of anagen development and initiation of catagen phase ally causing hair loss. The aim of our study was to assess the level of bFGF and TGF-beta 1 in alopecia areata patients’ serum. There were no significant difference in bFGF and TGF-beta 1 levels between alopecia areata patients’ and normal controls’ serum. Nevertheless, further studies on the role of angiogenesis in AA pathogenesis should be conducted to establish the novel therapeutic options for AA.
keywords:

alopecia areata, hair follicle, angiogenesis, bFGF, TGF-beta 1

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.